Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 261-222-3 | CAS number: 58353-68-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 120 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Reliable quality (Klimisch 2)
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No
data were available for registered substance, however data were
available for read-across substances:
- 'Butanoic acid, 4-amino-4-oxo-2(or 3)-sulfo-, N-(C16-C18 (even
numbered), C18 unsaturated alkyl), disodium salts'
- CAS No. 577-11-7 'Docusate sodium'.
Justification for read-across with category members is provided in
Section 13.
Screening
study
-
Reproductive toxicity of read-across substance 'Butanoic acid,
4-amino-4-oxo-2(or 3)-sulfo-, N-(C16-C18 (even numbered), C18
unsaturated alkyl), disodium salts' was tested in a combination repeated
dose/reproduction and developmental toxicity screening study according
to OECD TG 422 (Hansen, 2013a). The test item was administered orally by
gavage containing 25.5% active ingredient to rats at dose levels of 60,
120 or 300 mg act.ingr./kg bw/day. Day of sacrifice was on test day 37
for the male rats and on lactation day 4 or shortly thereafter for the
female rats. One of 10 male and one of 10 female animals both at 120 and
300 mg/kg bw/day died prematurely. At 300 mg/kg bw/day clinical signs in
form of salivation, pilo-erection and/or breathing sounds were noted in
a few male and female animals for 1 or 2 test days. A statistically
significant reduction in body weight was noted in both sexes at 300
mg/kg bw/day. Accordingly, food consumption and body weight were
statistically significantly reduced in both sexes at 300 mg/kg bw/day.
Haematology showed statistically significant changes at 300 mg test
item/kg bw/day, including increased MCH and decreased aPTT time (male
animals) and increased No. white blood cells and lymphocytes (female
animals). Changes in the relative or absolute organ weights of several
organs were noted for the male animals dosed at 300 mg test item/kg
bw/day, most remarkably for the relative liver weight which increased
for almost 20%.The macroscopic and microscopic examinations revealed no
test item related changes. NOAEL for paternal/maternal toxicity was 120
mg/kg bw (see Section 7.5.1). A statistically significant increase was
noted for the pre-implantation loss and post-Implantation loss index at
300 mg test item/kg bw/day. Correlating, the gestation index, the birth
index and the mean number of pups per dam were statistically
significantly reduced at 300 mg test item/kg bw/day.
- In conclusion, reproductive findings were considered to be secondary to the paternal/maternal toxicity. NOAEL-levels were 120 mg/kg bw for paternal/maternal toxicity and 120 mg/kg bw for reproductive toxicity.
Multigeneration
studies
Further
data on reproductive toxicity were available from read across substance
Docusate sodium (CAS No. 577-11-7). Justification for read across with
the category of Di-ester sulphosuccinates is documented in a separate
document attached in Section 13. - A key 3-generation toxicity study at
dietary dose levels of 0.1, 0.5 and 1.0% in the diet (MacKenzie, 1986)
conducted according to OECD caused a reduction in body weights at the
dose levels of 0.5 and 1% in the diet for parental males of all
generations and for F1 and F2 females. Pup weights at the 0.5% and 1.0%
dose levels were lower than those of the control in all three
generations, however this did not interfere with growth and development
or reproductive performance, and had no adverse effects at levels on the
reproductive function of either sex in any generation up to 1%. There
were no other effects on parental or reproductive parameters. The NOEL
for body weights of parental animals and offspring was 0.1%; the NOEL
for reproductive parameters was 1.0%, which was considered to correspond
with approximately 750 mg/kg bw/day. - In a supporting 2-generation
toxicity study in rats, 0.5 and 1% were given in the diet (Levinskas &
Shaffer, 1970). In the first mating of the F0 generation and the second
mating of the F2 generation, pups were weaned directly onto the diets
which were being fed to their parents. In the other 3 matings of this
study, dams were given a control diet on the day before delivery to
avoid a bitter taste of the milk. Pups of all litters were examined for
gross defects. Autopsies were performed, however, only on pups from the
first mating of the F2 animals. Portions of all major organs were taken
for histopathology processing and examination from one male and female
from each litter. The other male and female were skinned and
eviscerated, and the carcasses cleared, and the skeletons stained and
examined for defects. In both the first mating of the F0 generation and
the second mating of the F2 generation, the fertility and gestation
indices were high and comparable. The viability index was good, albeit
slightly down for the F3b pups, while the lactation index was depressed
for both of these matings. In addition, the mean weight of the pups at
weaning decreased with increasing concentrations of test material in the
diet of the dams. In the second mating of the F0 animals, the viability
and lactation indices and the mean weight of the test pups at weaning
still showed decreases relative to the control values. However, in the 2
subsequent matings, all indices for the dosed animals were numerically
high and compared favorably with the corresponding control values. Also,
the mean weight of the pups at weaning was essentially similar for all
groups. Consequently, it is concluded that diets containing 1% or less
had no adverse effect on the reproduction and lactation performance of
rats. The lowering of the survival rate and the mean body weight of the
F1a and F3b pups is attributed to an impairment of nutrition as a result
of the taste which is believed to have been secreted into the milk of
the dams. Microscopic study of tissues showed findings which were
similar in all groups. In processing the skeletons, the presence of an
extra sternebrae in the sternum between the 5th and 6th sternebrae was
not considered to parental exposure of test material. It is concluded
that feeding of test material to rats from weaning through reproductive
age for successive generations at levels of 1%, or less, did not produce
lesions or anomalies in the offspring which could be attributed to the
compound.
- In conclusion, 2 multigeneration studies with read-across substance CAS no. 577 -11 -7 (Docusate sodium) showed that there were no reproductive findings.
Conclusion
An
oral gavage reproductive screening study with read across substance
Butanoic acid, 4-amino-4-oxo-2(or 3)-sulfo-, N-(C16-C18 (even numbered),
C18 unsaturated alkyl), disodium salts showed NOAEL of 120 mg/kg bw for
paternal/maternal systemic toxicity, and for reproductive toxicity.
Reproductive toxicity findings at 300 mg/kg bw were considered secondary
to parental toxicity findings.
Multigeneration studies with read across substance Docusate sodium (CAS 577-11-7) showed slight maternal/paternal toxicity at 0.5 and 1% in the diet, however this was not confirmed in the second study. From both studies, it can be concluded that the substance up to 1% in the diet did not lead to effects on fertility or postnatal development; this concentration corresponds with 750 mg/kg bw/day. Based on the scondary reproductive findings in the screening study, and absence of reproductive toxicity findings in the multigeneration studies with structurally similar read-across substances, no reproductive potential is assumed for registered substance and no further testing is needed.
Short description of key information:
A key study for reproductive toxicity was performed in rats by means of an OECD 422 study with read-across substance 'Butanoic acid, 4-amino-4-oxo-2(or 3)-sulfo-, N-(C16-C18 (even numbered), C18 unsaturated alkyl), disodium salts' given by oral gavage at dose levels of 60, 120 and 300 mg act.ingr./kg bw/day. At the dose of 120 mg/kg bw, no adverse effects were observed, therefore NOAEL for paternal/maternal toxicity was 120 mg/kg bw/day. Findings at 300 mg/kg bw/day included mortality, clinical signs, reduced body weight and reduced food consumption, haematological and organ weight changes, most remarkably for the liver. There were no macroscopic or microscopic findings. An increase was noted for the pre-implantation loss and post-implantation loss index at 300 mg test item/kg bw/day. Correlating, the gestation index, the birth index and the mean number of pups per dam were statistically significantly reduced at 300 mg test item/kg bw/day. The findings were considered to be secondary to the paternal/maternal toxicity. NOAEL for reproductive toxicity was 120 mg/kg bw/day.
Read-across from CAS no. 577-11-7 (Docusate sodium) three-generation study according to OECD TG 416 and GLP showed decreased body weights in P, F1 and F2 generations at 0.5 and 1% dietary concentrations (the latter corresponding with 750 mg/kg bw), however these were not considered adverse and were not associated with any other (reproductive) findings. In a second (supporting) two-generation study the highest concentration of 1% in the diet corresponding to 750 mg act. ingr./kg bw was NOAEL.
Justification for selection of Effect on fertility via oral route:
Key study
Effects on developmental toxicity
Description of key information
Developmental toxicity was not observed in the oral combined repeated dose and reproduction/development screening study according to OECD guideline 422 with read-across substance 'Butanoic acid, 4-amino-4-oxo-2(or 3)-sulfo, N (C16-C18(even numbered), C18 unsaturated alkyl), disodium salts', in which rats were dosed at 60, 120 and 300 mg act. ingr./kg bw/day. Up to the dose of 120 mg/kg bw, no adverse effects were observed, therefore NOAEL for paternal/maternal toxicity was 120 mg/kg bw/day. Findings at 300 mg/kg bw/day included mortality, clinical signs, reduced body weight and reduced food consumption, haematological and organ weight changes, most remarkably for the liver. There were no macroscopic or microscopic findings. NOAEL for developmental toxicity was 300 mg/kg bw/day.
Prenatal developmental toxicity was tested by dietary administration of read across substance Docusate sodium in rats from day 6 to 15 of gestation. 1% in the diet was a maternal and developmental NOAEL, whereas at 2% in the diet visceral and skeletal anomalies were observed, which was secondary to maternal toxicity. This was confirmed in a similar study with Docusate calcium given at subtoxic and toxic dose levels, where the same could be observed.
Based on the absence of developmental findings in the screening study and teratogenicity study with structurally similar read-across substances, no developmental toxicity potential is assumed for registered stubstance and no further testing is needed.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 074 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Reliable quality (Klimisch 2)
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No
data were available for registered substance, however data were
available for read-across substances
- 'Butanoic acid, 4-amino-4-oxo-2(or 3)-sulfo-, N-(C16-C18 (even
numbered), C18 unsaturated alkyl), disodium salts'.
- CAS No. 577-11-7 (Docusate sodium).
Justification for read-across with category members is provided in
Section 13.
Developmental
toxicity screening
Developmental
toxicity of read-across substance 'Butanoic acid, 4-amino-4-oxo-2(or
3)-sulfo-, N-(C16-C18 (even numbered), C18 unsaturated alkyl), disodium
salts' was tested in a combination repeated dose/reproduction and
developmental toxicity screening study according to OECD TG 422 (Hansen,
2013a). The test item was administered orally by gavage containing 25.5%
active ingredient to rats at dose levels of 60, 120 or 300 mg
act.ingr./kg bw/day. Day of sacrifice was on test day 37 for the male
rats and on lactation day 4 or shortly thereafter for the female rats.
One of 10 male and one of 10 female animals both at 120 and 300 mg/kg
bw/day) died prematurely. At 300 mg/kg bw/day clinical signs in form of
salivation, pilo-erection and/or breathing sounds were noted in a few
male and female animals for 1 or 2 test days. A statistically
significant reduction in body weight was noted in both sexes at 300
mg/kg bw/day. Accordingly, food consumption and body weight were
statistically significantly reduced in both sexes at 300 mg/kg bw/day.
Haematology showed statistically significant changes at 300 mg test
item/kg bw/day, including increased MCH and decreased aPTT time (male
animals) and increased No. white blood cells and lymphocytes (female
animals). Changes in the relative or absolute organ weights of several
organs were noted for the male animals dosed at 300 mg test item/kg
bw/day, most remarkably for the relative liver weight which increased
for almost 20%. The macroscopic and microscopic examinations revealed no
test item related changes. NOAEL for paternal/maternal toxicity was 120
mg/kg bw (see Section 7.5.1). A statistically significant increase was
noted for the pre-implantation loss and post-implantation loss index at
300 mg test item/kg bw/day. Correlating, the gestation index, the birth
index and the mean number of pups per dam were statistically
significantly reduced at 300 mg test item/kg bw/day. These findings were
considered secondary to the maternal/paternal toxicity at 300 mg/kg
bw/day. The NOAEL for reproductive toxicity NOAEL was 120 mg/kg bw/day.
No adverse effect was noted on the development of the pups from the dams
of the high dose group (300 mg test item/kg bw/day), as there was no
reduction in the survival index or the litter weight of the pups.
In conclusion, the NOAEL for developmental toxicity was 300 mg/kg bw/day, however the study was considered to be supporting.
Teratogenicity
testing
Further
data on prenatal developmental toxicity were available from read across
substance Docusate sodium (CAS No. 577-11-7). Justification for read
across with the category of Di-ester sulphosuccinates is documented in a
separate document attached in Section 13.
- A key study for prenatal developmental toxicity was performed in rats
dosed from day 6-15 of gestation with read across substance Docusate
sodium dosed at dietary dose levels of 1.0 and 2.0 % in the diet (Roell
et al., 1976). The study was conducted according to OECD 414 guideline,
and was considered to be reliable, adequate and relevant. Subtoxic
dietary levels of 1.0% showed no adverse effects on the various maternal
or fetal parameters. Toxic dietary levels of 2.0% Docusate sodium
produced significant depressions in maternal weight-gains and increased
incidences of resorptions (13.7%) and gross abnormalities either among
litters (25.0%) or fetal populations (20.2%) as compared to controls.
These abnormalities consisted primarily of exencephaly of varying
degrees with, at times, spina bifida, anophthalmia and associated
skeletal defects. The visceral observations confirmed the significance
of the exencephalous characteristics and anophthalmia for the group
given dietary levels of 2.0%. In this group, skeletal observations
revealed a significant incidence of incomplete ossification to absence
of the various cranial bones, a curved or open vertebral column, and a
variety of defects of the vertebrae and ribs. Interpretation of the
results of the present experiment, in which only maternally toxic doses
induce teratogenicity, indicates no real hazard with the recommended
human use of these surfactants. The concentration of 1% in the diet is
considered as maternal and developmental NOAEL. This dose level
corresponded with a test article intake of 1074 mg/kg body weight, as
calculated in the study.
- As supporting information, prenatal developmental toxicity was also
studied in rats by dietary administration of Docusate 'calcium' (DCS) at
dose levels of 0.5, 1.0, 1.5 and 2.0 % in the diet as well as by oral
gavage at 250, 500, 750 and 1000 mg/kg bw (Roell et all., 1976).
Subtoxic dietary levels of 0.5 and 1.0% Docusate calcium ingested on
gestational days 6 through 15 showed no adverse effects on the various
maternal or fetal parameters. Near toxic or toxic dietary levels of 1.5
and 2.0% DCS produced significant incidences of resorptions and gross
abnormalities consisting primarily of exencephaly of varying degrees
with spina bifida, anophthalmia and associated skeletal
defects. However, dietary levels of 2% of DCS fed to pregnant rats for 3
days (days 6-8, 8-10 or 10-12) did not produce teratogenic response.
Also, DCS given to pregnant rats by oral intubation at maternally
subtoxic doses (250-750 mg/kg) and a slightly toxic dose (1000 mg/kg)
did not lead to malformations, however the incidence of resorptions was
increased at the 2 toxic doses. Likewise doses of 500 and 750 mg/kg
given by gavage from day 6-15 produced an increase in resorptions at the
highest dose without a teratogenic effect. Since only maternally toxic
doses fed on gestational day 6-15 produced embryotoxic and teratogenic
effects, it is concluded that no real hazard exists.
Conclusion
An
oral gavage reproductive/developmental screening study with read across
substance Butanoic acid, 4-amino-4-oxo-2(or 3)-sulfo-, N-(C16-C18 (even
numbered), C18 unsaturated alkyl), disodium salts showed NOAEL of 120
mg/kg bw for paternal/maternal systemic toxicity and for reproductive
toxicity, whereas 300 mg/kg bw was NOAEL for developmental toxicity.
Prenatal developmental toxicity was tested by dietary administration of read across substance Docusate sodium in rats from day 6 to 15 of gestation. 1% in the diet was a maternal and developmental NOAEL corresponding to 1074 mg/kg bw, whereas at 2% in the diet visceral and skeletal anomalies were observed, which were considered secondary to maternal toxicity. This was confirmed in a similar study with Docusate calcium given at subtoxic and toxic dose levels, where the same could be observed.
Based on the absence of developmental findings in the screening study and teratogenicity studies with structurally similar read-across substances, no developmental toxicity potential is assumed for the registered substance, and no further testing is needed.
Justification for selection of Effect on developmental toxicity: via oral route:
Key study
Justification for classification or non-classification
Based on these results and according to the EC Directive (No.93/21/EEC) and CLP (No. 1272/2008 of 16 December 2008), the test substance does not have to be classified and has no obligatory labelling requirement for reproductive and developmental toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.